bonafton has been researched along with pentoxifylline in 1 studies
*Pentoxifylline: A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production. [MeSH]
*Pentoxifylline: A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shumskiĭ, AV | 1 |
1 other study(ies) available for bonafton and pentoxifylline
| Article | Year |
|---|---|
[Lymphotropic therapy with trental in the treatment of chronic herpetic stomatitis].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antibody Formation; Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Humans; Hyaluronoglucosaminidase; Immunity, Cellular; Immunity, Innate; Injections, Intralymphatic; Naphthoquinones; Pentoxifylline; Stomatitis, Herpetic | 1997 |